FORESIGHT® HCV ANTIBODY EIA TEST KIT
Mexico·Clase II·III. DIAGNOSTIC AGENTS·KABLA COMERCIAL, S.A. DE C.V.·Registered November 29, 2018FORESIGHT® HCV ANTIBODY EIA TEST KIT, ES UN INMUNOENZAYO ENZIMÁTICO, CUALITATIVO PARA LA DETECCIÓN DE ANTICUERPOS IGG CONTRA EL VIRUS DE LA HEPATITIS C EN SUERO O PLASMA HUMANO.
FORESIGHT® HCV ANTIBODY EIA TEST KIT, IS AN ENZYMATIC, QUALITATIVE IMMUNOENZAYO FOR THE DETECTION OF IGG ANTIBODIES AGAINST HEPATITIS C VIRUS IN SERUM OR HUMAN PLASMA.
- Risk Class / Clase de Riesgo
- Clase II
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- KIT PARA LA DETECCIÓN DE ANTICUERPOS HCV PARA SANGRE ENTERA
- Trade Name (English)
- WHOLE BLOOD HCV ANTIBODY DETECTION KIT
- Analysis ID
- 2674R2018 SSA
- Registration Date
- November 29, 2018
- Name (Spanish)
- KABLA COMERCIAL, S.A. DE C.V.
- Name (English)
- KABLA COMERCIAL, S.A. DE C.V.
Access comprehensive regulatory information for FORESIGHT® HCV ANTIBODY EIA TEST KIT (FORESIGHT® HCV ANTIBODY EIA TEST KIT) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 2674R2018 SSA and manufactured by KABLA COMERCIAL, S.A. DE C.V.. The device was registered on November 29, 2018.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.